Bangkok Genomics Innovation PCL (BKK:BKGI)
2.060
+0.060 (3.00%)
Jun 4, 2026, 4:37 PM ICT
BKK:BKGI Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Net Income | 68.46 | 45.35 | 50.17 | 32.14 | 75.11 |
Depreciation & Amortization | 21.83 | 20.81 | 17.19 | 15.4 | 14.28 |
Other Amortization | 0.73 | 0.73 | 0.6 | 0.56 | 0.26 |
Loss (Gain) From Sale of Assets | - | - | - | -0 | -0.03 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | - | 0.03 | 0 |
Loss (Gain) on Equity Investments | 0.26 | 0.32 | 0.08 | - | - |
Provision & Write-off of Bad Debts | 2.96 | 1.87 | 1.38 | -0.75 | -0.9 |
Other Operating Activities | 5.58 | -0.8 | -0.49 | 2.69 | 3.03 |
Change in Accounts Receivable | -176.47 | -222.44 | -56.45 | 5.7 | -0.06 |
Change in Inventory | -41.42 | -13.86 | -12.22 | 7.34 | -3.77 |
Change in Accounts Payable | 64.66 | 74.09 | 8.54 | 11.12 | -5.37 |
Change in Other Net Operating Assets | 1.12 | 1.6 | -12.31 | -2.38 | -1.83 |
Operating Cash Flow | -52.27 | -92.32 | -3.5 | 71.85 | 80.74 |
Operating Cash Flow Growth | - | - | - | -11.02% | - |
Capital Expenditures | -16.02 | -15.1 | -19.96 | -4.82 | -26.84 |
Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.44 |
Sale (Purchase) of Intangibles | -22.2 | -21.17 | - | -0.26 | -1.34 |
Investment in Securities | 79.79 | 89.99 | -151.01 | -40 | -0 |
Other Investing Activities | -56.7 | -5.27 | 1.07 | 0.53 | 26.68 |
Investing Cash Flow | -15.14 | 48.46 | -169.9 | -44.55 | -1.06 |
Long-Term Debt Repaid | - | -5.78 | -5.62 | -5.66 | -5.44 |
Net Debt Issued (Repaid) | -5.9 | -5.78 | -5.62 | -5.66 | -5.44 |
Issuance of Common Stock | - | - | 260.8 | - | 190 |
Common Dividends Paid | -28.08 | -28.08 | - | -44 | -166.5 |
Other Financing Activities | -1.96 | 0 | -7.63 | - | - |
Financing Cash Flow | -35.94 | -33.86 | 247.56 | -49.66 | 18.06 |
Foreign Exchange Rate Adjustments | -0.38 | -0.49 | -0.14 | -0.09 | -0.04 |
Net Cash Flow | -103.72 | -78.2 | 74.02 | -22.46 | 97.69 |
Free Cash Flow | -68.29 | -107.41 | -23.46 | 67.03 | 53.9 |
Free Cash Flow Growth | - | - | - | 24.36% | - |
Free Cash Flow Margin | -15.07% | -28.30% | -6.95% | 27.31% | 17.68% |
Free Cash Flow Per Share | -0.11 | -0.18 | -0.04 | 0.15 | 0.25 |
Cash Income Tax Paid | 1.32 | 1.32 | 0.85 | 1.85 | 1.91 |
Levered Free Cash Flow | -98.92 | -137.74 | -38.87 | 58.2 | - |
Unlevered Free Cash Flow | -98.04 | -136.84 | -38.02 | 59.22 | - |
Change in Working Capital | -152.11 | -160.62 | -72.44 | 21.77 | -11.03 |